BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Lucke-Wold B, Rangwala BS, Shafique MA, Siddiq MA, Mustafa MS, Danish F, Nasrullah RMU, Zainab N, Haseeb A. Focus on current and emerging treatment options for glioma: A comprehensive review. World J Clin Oncol 2024; 15(4): 482-495 [PMID: 38689623 DOI: 10.5306/wjco.v15.i4.482]
URL: https://www.wjgnet.com/2218-4333/full/v15/i4/482.htm
Number Citing Articles
1
Yujing Wen, Wenhao Zhou, Zhenzhen Zhao, Didi Ma, Jian Mao, Yingjie Cai, Fugui Liu, Juan Zhou, Kun Lv, Wenchao Gu, Lan Jiang. Annexin A’s Life in Pan-Cancer: Especially in Glioma Immune CellsNeuroMolecular Medicine 2025; 27(1) doi: 10.1007/s12017-024-08827-9
2
Lei Li, Jiang-hua Yang, Xin-meng Fa, Ming-song Liu, Qi-lin Wang, Tong-fei Zeng, Rui-zhe Chen, Jun Ou, Xue-wei Xia. Preliminary investigation of nitric oxide release from upconverted nanoparticles excited at 808 nm near-infrared for brain tumorsHeliyon 2024; 10(13): e33576 doi: 10.1016/j.heliyon.2024.e33576
3
Laura Marinela Ailioaie, Constantin Ailioaie, Gerhard Litscher. Fighting Cancer with Photodynamic Therapy and Nanotechnologies: Current Challenges and Future DirectionsInternational Journal of Molecular Sciences 2025; 26(7): 2969 doi: 10.3390/ijms26072969
4
Zongye Zhang, Zhi Sha, Hao Wang, Yusheng Chen, Zhendong Liu, Xingbo Cheng, Sujie Gu, Yanzheng Gao. PSMC3IP as a prognostic biomarker and immunomodulatory regulator in low-grade glioma: insights from multi-omics and methylation analysisNeurological Research 2025; : 1 doi: 10.1080/01616412.2025.2528159
5
Yan Li, Fanjing Jiang, Suhua Zhu, Hongwei Jia, Changwei Li. STAT3 drives the malignant progression of low-grade gliomas through modulating the expression of STAT1, FOXO1, and MYCFrontiers in Molecular Biosciences 2024; 11 doi: 10.3389/fmolb.2024.1419072
6
Xixi Wei, Yang Wang, Wanlong Zhao, Wenqian Yang, Jiaping Tang, Baosheng Zhao, Yuzhen Liu. Knockdown of ACC1 promotes migration and invasion of U251 glioma cells by epigenetically suppressing SDHInternational Journal of Oncology 2025; 67(3): 1 doi: 10.3892/ijo.2025.5779
7
George B. H. Green, Alexis N. Cox-Holmes, Anna Claire E. Potier, Gillian H. Marlow, Braden C. McFarland. Modulation of the Immune Environment in Glioblastoma by the Gut MicrobiotaBiomedicines 2024; 12(11): 2429 doi: 10.3390/biomedicines12112429
8
Simin Wang, Jiyong Wu, Wenfei Zhang, Jing Nie. Effects and safety of TMZ plus RT combined with other drugs in the treatment of glioblastoma: a network meta-analysisFuture Oncology 2025; 21(17): 2237 doi: 10.1080/14796694.2025.2516408
9
Muhammad Khan, Xiuting Huang, Xiaoxin Ye, Donghui Zhang, Baiyao Wang, Anan Xu, Rong Li, Anbang Ren, Chengcong Chen, Jingjing Song, Rong Zheng, Yawei Yuan, Jie Lin. Necroptosis-based glioblastoma prognostic subtypes: implications for TME remodeling and therapy responseAnnals of Medicine 2024; 56(1) doi: 10.1080/07853890.2024.2405079
10
Ivana Karmelić, Mia Jurilj Sajko, Tomislav Sajko, Krešimir Rotim, Dragana Fabris. The role of sphingolipid rheostat in the adult-type diffuse glioma pathogenesisFrontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1466141